Plenivida Opens Invitations for Clinician-Guided Medicine Built for Women in Midlife
Oct 19, 2026
New U.S. telehealth brand brings hormone health, medical weight care and peptide therapy into one place, with independent clinical review at the center and baseline lab testing into every patient journey.
Newport Beach, California Oct 19, 2026 (Issuewire.com) - Plenivida, a U.S. telehealth brand built for women 45 to 60, today opened requests for invitation ahead of its launch. The company is preparing care for perimenopause and menopause, medical weight management and peptide therapy, each grounded in individual clinical evaluation and ongoing follow-up.
Midlife medicine arrives in pieces. Weight is discussed in one appointment, hormones in another, and questions about peptides end in online searches with no one to ask. Plenivida was built to hold those conversations in one place, while every treatment decision stays individual.
"Menopause is not a mood, and weight in midlife is not a question of willpower," said Fabricio Alves, founder of Plenivida. "Women at this stage expect more from their medicine than a product menu. They expect a clinician who reads their history and explains what comes next."
A care plan begins before the prescription
Every Plenivida pathway starts with a medical intake and an independent clinical review. Medical history, current medications and laboratory information are considered as appropriate to each evaluation, and additional testing may be requested when clinically indicated.
A licensed clinician decides whether treatment is suitable, and in some cases the right decision is not to prescribe. When a treatment is prescribed, an independently licensed pharmacy fulfills it. Follow-up and direct communication with the care team are part of every program.
Three areas of care
- Hormone health and menopause: clinical evaluation for women in perimenopause and menopause.
- Medical weight and metabolic health: individualized evaluation of weight treatment options, with clinician-guided decisions and follow-up.
- Peptide therapy and longevity: evaluation of prescription-based peptide services, subject to clinical appropriateness and applicable regulation.
Requests for invitation are open
Women can request an invitation at plenivida.health. A request is free, carries no obligation and does not create a clinician-patient relationship or guarantee eligibility, a prescription or access to any treatment. Availability depends on state law, clinical evaluation and pharmacy requirements. Information is available in English and Spanish.
About Plenivida
Plenivida is a U.S. telehealth brand for women in midlife, bringing hormone health, medical weight management and peptide therapy into one place, with an emphasis on clinical judgment and continuity of care. Plenivida is operated by JOINFORM, LLC and is a software and services platform, not a medical practice or pharmacy. Clinical services and prescribing decisions are provided by independent licensed clinicians, and medications by independently licensed pharmacies when prescribed and legally permitted.
Source :Plenivida Health
This article was originally published by IssueWire. Read the original article here.
More News
The ‘Ozempic face’ discovery that revived a fading giant
A surprise discovery may have saved one of the world’s oldest chemical companies from sliding into irrelevance.
Stax is back, saved by founders of sneakerhead marketplace
The athleisure brand collapsed in June after an ill-fated retail expansion, but now a new entrepreneurial couple plans to revive it.
Australia clashes with Asian energy giants over gas export crackdown
Labor is risking a backlash from major Asian partners as it forges ahead with contentious rules to divert more gas exports to local consumers.
‘Only the sharks are left’: The $388 billion change shaking up the sharemarket
There’s been a major shift in how Australians buy shares, sparking debate over whether our market is becoming more prone to wild swings – or even the risk of bubbles.
Trying to find a job is now as toxic as dating apps. I want a career, not a booty call
Recruiters, your “booty calls” are wearing thin. And it’s time to give up the “ghost”.
Drones as first responders: welcome to the future of policing
Drones have a bird’s-eye view of the city. The prospect of police departments integrating drones into their workflow raises questions about privacy and police accountability.
The $38b battle for Australia’s top gold miner may be just beginning
A South African mining giant is seeking to rally investors across Australia to pressure a major local rival into takeover talks.
Weighing the real cost of migration cuts
An analysis using Parliamentary Budget Office tools shows that One Nation’s immigration policy may add an extra $275 billion to national debt.
A first look at Western Sydney airport’s new international lounge
The new airport has revealed details of an 80-seat mezzanine level facility which will feature a dining area, a bar, an open kitchen, private shower suites and a view of the Blue Mountains.
Ground zero: America’s heartland hit by the fallout of Trump’s bomb
The effects of Donald Trump’s war against Iran and various trade wars are spreading through the US, and rural America is feeling the pain.
Damned if you work, damned if you retire: The Baby Boomers stuck in a catch-22
It’s a generation that has been defined by a fat-cat minority – but Boomers are increasingly working well past retirement age.
EV boom zaps second-hand prices for petrol and diesel cars
As Australian drivers upgrade to EVs, they’re offloading their old fuel-reliant cars en masse – and prices are falling rapidly.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.